← Leaderboards
Carlos Austin Zamarripa
University Of Mississippi Med Ctr
$1,086,132
Attributed
$2,090,117
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,090,117 · 3
By mechanism
R01$2,007,971 · 2
F31$82,146 · 1
Top collaborators
- Meghan Bridgid Moran2 shared
- Eric C Strain1 shared
Most similar at University Of Mississippi Med Ctr
Same institution · by research overlap
- Sumana Ghosh$232,500
Others in their field
Other Emerging Leaders on “Public Health”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Mark Marino · Venturewell$51,488,542
- Susan M Landau · University Of California Berkeley$47,252,026
- Leonard Freedman · Leidos Biomedical Research, Inc.$39,554,144
Research focus
Public HealthPharmaceutical PreparationsDesignReportingMaleMethodologyOxycodoneOpioidPathway InteractionsDoseFreund&AposCognitive PerformanceAdultFentanylCoupledFemaleG-Protein-Coupled ReceptorsExhibitsBehavioralAddictionAgonistBeta-ArrestinAcetic AcidsEfficacy Testing
Grant awards (6)
Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes$720,929
R01 · FY2025 · DA
Evaluating kratom using a human drug development methodology$597,896
R01 · FY2025 · DA · contact PI
Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes$689,146
R01 · FY2024 · DA
Therapeutic selectivity of biased mu-opioid agonists.$13,490
F31 · FY2021 · DA · contact PI
Therapeutic selectivity of biased mu-opioid agonists.$34,580
F31 · FY2020 · DA · contact PI
Therapeutic selectivity of biased mu-opioid agonists.$34,076
F31 · FY2019 · DA · contact PI